Cargando…

Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features

We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Nainggolan, Ita M., Harahap, Alida, Ambarwati, Debby D., Liliani, Rosalina V., Megawati, Dewi, Swastika, Maria, Setianingsih, Iswari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667679/
https://www.ncbi.nlm.nih.gov/pubmed/23614625
http://dx.doi.org/10.3109/03630269.2013.775149
_version_ 1782271515503362048
author Nainggolan, Ita M.
Harahap, Alida
Ambarwati, Debby D.
Liliani, Rosalina V.
Megawati, Dewi
Swastika, Maria
Setianingsih, Iswari
author_facet Nainggolan, Ita M.
Harahap, Alida
Ambarwati, Debby D.
Liliani, Rosalina V.
Megawati, Dewi
Swastika, Maria
Setianingsih, Iswari
author_sort Nainggolan, Ita M.
collection PubMed
description We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by routine procedures. The genotypes were generated by a multiplex-polymerase chain reaction (m-PCR), PCR-RFLP (restriction fragment length polymorphism)-based method, and DNA sequencing. The α-thal patients who had Hb Adana in combination with the 3.7 kb deletion mostly have mild-to-moderate anemia. In contrast, patients who were compound heterozygotes for Hb Adana and nondeletional mutations, generally showed a more severe anemia and it mostly presented in childhood. Thus, accurate diagnosis of α-thal disorders is not only important for future management of these patients but also for providing proper genetic counseling to the family.
format Online
Article
Text
id pubmed-3667679
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-36676792013-05-31 Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features Nainggolan, Ita M. Harahap, Alida Ambarwati, Debby D. Liliani, Rosalina V. Megawati, Dewi Swastika, Maria Setianingsih, Iswari Hemoglobin Short Communication We describe 27 cases of mild-to-severe α-thalassemia (α-thal) syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp, GGC>GAC (α2)] with deletional and nondeletional α(+)-thal mutations in Indonesian patients. Hematological profiles and clinical manifestations of all patients were assessed by routine procedures. The genotypes were generated by a multiplex-polymerase chain reaction (m-PCR), PCR-RFLP (restriction fragment length polymorphism)-based method, and DNA sequencing. The α-thal patients who had Hb Adana in combination with the 3.7 kb deletion mostly have mild-to-moderate anemia. In contrast, patients who were compound heterozygotes for Hb Adana and nondeletional mutations, generally showed a more severe anemia and it mostly presented in childhood. Thus, accurate diagnosis of α-thal disorders is not only important for future management of these patients but also for providing proper genetic counseling to the family. Informa Healthcare 2013-06 2013-04-24 /pmc/articles/PMC3667679/ /pubmed/23614625 http://dx.doi.org/10.3109/03630269.2013.775149 Text en © Informa Healthcare USA, Inc. http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Short Communication
Nainggolan, Ita M.
Harahap, Alida
Ambarwati, Debby D.
Liliani, Rosalina V.
Megawati, Dewi
Swastika, Maria
Setianingsih, Iswari
Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title_full Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title_fullStr Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title_full_unstemmed Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title_short Interaction of Hb Adana (HBA2: c.179G>A) with Deletional and Nondeletional α (+)-Thalassemia Mutations: Diverse Hematological and Clinical Features
title_sort interaction of hb adana (hba2: c.179g>a) with deletional and nondeletional α (+)-thalassemia mutations: diverse hematological and clinical features
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667679/
https://www.ncbi.nlm.nih.gov/pubmed/23614625
http://dx.doi.org/10.3109/03630269.2013.775149
work_keys_str_mv AT nainggolanitam interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT harahapalida interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT ambarwatidebbyd interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT lilianirosalinav interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT megawatidewi interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT swastikamaria interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures
AT setianingsihiswari interactionofhbadanahba2c179gawithdeletionalandnondeletionalathalassemiamutationsdiversehematologicalandclinicalfeatures